Endovascular Treatment of Symptomatic Vasospasm after Aneurysmal Subarachnoid Hemorrhage: A Three-year Experience
Authors:
Open Access
- 1 January 2017
- journal article
- Published by Korean Society of Cerebrovascular Surgeons/Korean Society of Endovascular Surgery in Journal of Cerebrovascular and Endovascular Neurosurgery
- Vol. 19 (3) , 155-161
Abstract
The cause of severe clinical vasospasm after aneurysmal subarachnoid hemorrhage remains unknown, despite extensive research over the past 30 years. However, the intra-arterial administration of vasodilating agents and balloon angioplasty have been successfully used in severe refractory cerebral vasospasm. We retrospectively analyzed the data of 233 patients admitted to our institute with aneurysmal subarachnoid hemorrhage (SAH) over the past 3 years. Of these, 27 (10.6%) developed severe symptomatic vasospasm, requiring endovascular therapy. Vasospasm occurred at an average of 5.3 days after SAH. A total of 46 endovascular procedures were performed in 27 patients. Endovascular therapy was performed once in 18 (66.7%) patients, 2 times in 4 (14.8%) patients, 3 or more times in 5 (18.5%) patients. Intra-arterial vasodilating agents were used in 44 procedures (27 with nimodipine infusion, 17 with nicardipine infusion). Balloon angioplasty was performed in only 2 (7.4%) patients. The Average nimodipine infusion volume was 2.47 mg, and nicardipine was 3.78 mg. Most patients recovered after the initial emergency room visit. Two patients (7.4%) worsened, but there were no deaths. With advances in endovascular techniques, administration of vasodilating agents and balloon angioplasty reduces the morbidity and mortality of vasospasm after aneurysmal SAH.Keywords
Funding Information
- Wonkwang University
This publication has 47 references indexed in Scilit:
- Clazosentan to Overcome Neurological Ischemia and Infarction Occurring After Subarachnoid Hemorrhage (CONSCIOUS-1)Stroke, 2008
- Magnesium infusion for vasospasm prophylaxis after subarachnoid hemorrhageJournal of Neurosurgery, 2006
- Endovascular Treatment of Cerebral Vasospasm: Transluminal Balloon Angioplasty, Intra-Arterial Papaverine, and Intra-Arterial NicardipineNeurosurgery Clinics of North America, 2005
- Magnesium sulfate therapy after aneurysmal subarachnoid hemorrhageJournal of Neurosurgery, 2002
- Calcium Antagonists for Ischemic StrokeStroke, 2001
- Balloon Angioplasty for the Treatment of Vasospasm: Results of First 50 CasesNeurosurgery, 1998
- L-Type Ca2+Channel Blockers Attenuate Electrical Changes and Ca2+Rise Induced by Oxygen/Glucose Deprivation in Cortical NeuronsStroke, 1998
- Angioplasty for the treatment of symptomatic vasospasm following subarachnoid hemorrhageJournal of Neurosurgery, 1989
- Nimodipine: a new calcium antagonistic drug with a preferential cerebrovascular actionActa Neurochirurgica, 1982
- Papaverine Hydrochloride and Experimental Hemorrhagic Cerebral Arterial SpasmStroke, 1972